No Data
No Data
5 Things You Need to Know About COVID, Flu and RSV Vaccines This Fall
Sanofi on Pace for Highest Close Since April 2023 -- Data Talk
Inhibrx Gains After Insider Purchases From CEO
Biopharmaceuticals Global Business Report 2024 With Focus on 200+ Select Players Including Abbott, Amgen, Biogen, Eli Lilly and Co, F. Hoffmann-La Roche, J&J, Merck, Novo Nordisk, Pfizer, Sanofi
PAI Said to Rope in Sovereign Funds for Sanofi Consumer Unit Bid
FTC Says FDA Biosimilar Guidance Would Increase Competition, Lead to Lower Prices
No Data